Stability and heterogeneity of expression profiles in lung cancer specimens harvested following surgical resection

被引:45
作者
Blackhall, FH
Pintilie, M
Wigle, DA
Jurisica, I
Liu, N
Radulovich, N
Johnston, MR
Keshavjee, S
Tsao, MS
机构
[1] Princess Margaret Hosp, Ontario Canc Inst, Toronto Gen Hosp, Univ Hlth Network, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Toronto, ON M5G 2M9, Canada
来源
NEOPLASIA | 2004年 / 6卷 / 06期
基金
加拿大自然科学与工程研究理事会;
关键词
lung cancer; microarray; real-time RT-PCR; tumor heterogeneity; surgical specimen;
D O I
10.1593/neo.04301
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
One of the major concerns in microarray profiling studies of clinical samples is the effect of tissue sampling and RNA extraction on data. We analyzed gene expression in lung cancer specimens that were serially harvested from tumor mass and snap-frozen at several intervals up to 120 minutes after surgical resection. Global gene expression was profiled on cDNA microarrays, and selected stress and hypoxia-activated genes were evaluated using real-time reverse transcription polymerase chain reaction (RTPCR). Remarkably, similar gene expression profiles were obtained for the majority of samples regardless of the time that had elapsed between resection and freezing. Real-time RT-PCR studies showed significant heterogeneity in the expression levels of stress and hypoxia-activated genes in samples obtained from different areas of a tumor specimen at one time point after resection. The variations between multiple samplings were significantly greater than those of elapsed time between sampling/freezing. Overall samples snap-frozen within 30 to 60 minutes of surgical resection are acceptable for gene expression studies, thus making sampling and snap-freezing of tumor samples in a routine surgical pathology laboratory setting feasible. However, sampling and pooling from multiple sites of each tumor may be necessary for expression profiling studies to overcome the molecular heterogeneity present in tumor specimens.
引用
收藏
页码:761 / 767
页数:7
相关论文
共 24 条
  • [1] Gene-expression profiles predict survival of patients with lung adenocarcinoma
    Beer, DG
    Kardia, SLR
    Huang, CC
    Giordano, TJ
    Levin, AM
    Misek, DE
    Lin, L
    Chen, GA
    Gharib, TG
    Thomas, DG
    Lizyness, ML
    Kuick, R
    Hayasaka, S
    Taylor, JMG
    Iannettoni, MD
    Orringer, MB
    Hanash, S
    [J]. NATURE MEDICINE, 2002, 8 (08) : 816 - 824
  • [2] Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
    Bhattacharjee, A
    Richards, WG
    Staunton, J
    Li, C
    Monti, S
    Vasa, P
    Ladd, C
    Beheshti, J
    Bueno, R
    Gillette, M
    Loda, M
    Weber, G
    Mark, EJ
    Lander, ES
    Wong, W
    Johnson, BE
    Golub, TR
    Sugarbaker, DJ
    Meyerson, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) : 13790 - 13795
  • [3] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [4] Accurate gene expression measurement in formalin-fixed and paraffin-embedded tumor tissue
    D'Orazio, D
    Stumm, M
    Sieber, C
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (01) : 383 - 384
  • [5] Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens
    Dash, A
    Maine, IP
    Varambally, S
    Shen, R
    Chinnaiyan, AM
    Rubin, MA
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (05) : 1743 - 1748
  • [6] Diversity of gene expression in adenocarcinoma of the lung
    Garber, ME
    Troyanskaya, OG
    Schluens, K
    Petersen, S
    Thaesler, Z
    Pacyna-Gengelbach, M
    van de Rijn, M
    Rosen, GD
    Perou, CM
    Whyte, RI
    Altman, RB
    Brown, PO
    Botstein, D
    Petersen, I
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) : 13784 - 13789
  • [7] Giatromanolaki A, 2001, CANCER RES, V61, P7992
  • [8] Gene expressions after thrombolytic treatment of middle cerebral artery clot embolism in mice
    Hara, T
    Mies, G
    Hata, R
    Hossmann, KA
    [J]. STROKE, 2001, 32 (08) : 1912 - 1919
  • [9] Hedley D, 2003, CLIN CANCER RES, V9, P5666
  • [10] JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases
    Hu, MCT
    Qiu, WR
    Wang, YP
    [J]. ONCOGENE, 1997, 15 (19) : 2277 - 2287